In people with MS, a fluid-making area in the brain called the choroid plexus is larger and linked to thinning of the brain’s outer layer, which may relate to ongoing brain tissue loss.
Researchers measured the choroid plexus (a tiny structure that makes spinal fluid) and overall brain size in people with MS, another condition called NMOSD, and healthy volunteers. People with MS had a bigger choroid plexus than healthy people, but those with NMOSD did not. In MS patients, a larger choroid plexus was tied to a thinner cortex (the brain’s outer layer that handles thinking and feeling) across many brain areas. Over time, MS patients showed shrinkage (atrophy) in certain deep brain parts like the hippocampus (important for memory) and bigger fluid spaces (ventricles), suggesting progressive changes. These links between a bigger choroid plexus and brain shrinkage were seen in MS but were not obvious in NMOSD.
People living with MS and their caregivers should pay attention because this study points to a visible brain sign (bigger choroid plexus) that goes along with brain tissue loss, which could help doctors track disease changes. Think of the choroid plexus like a factory that makes fluid: if the factory looks bigger on scans, it might be a clue that nearby parts of the city (the brain) are shrinking. Neurologists and MS care teams may use this information to better understand how the disease is progressing and to explain MRI results to patients. This finding might eventually help guide decisions about monitoring or treatments, much like using a warning light to check a car. Caregivers can use this knowledge to ask informed questions about MRI findings and what they mean for memory, thinking, or daily function.
This study found associations but cannot prove the bigger choroid plexus causes brain shrinkage—other factors might be involved. The number of people followed over time was limited, so more research with longer follow-up is needed to confirm these patterns. The results do not mean every person with MS will have the same changes, so talk with your care team about what MRI findings mean for your individual care.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds a brain‑seeking CD4 killer cell tied to MS and CMV exposure that may resist some treatme
Read More5/1/2026
Study shows after optic neuritis the ganglion cell layer (GCL) loses more tissue than the inner plex
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds specific spinal fluid proteins tied to early nerve damage in active MS, highlighting imm
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like European radiology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.